Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The cerivastatin withdrawal crisis: a "post-mortem" analysis.

Marina Maggini1, Roberto Raschetti, Giuseppe Traversa

  • 1National Center of Epidemiology, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy. mmaggini@iss.it

Health Policy (Amsterdam, Netherlands)
|June 24, 2004
PubMed
Summary

Cerivastatin withdrawal in 2001 led to a 5% increase in patients discontinuing statin therapy. Concomitant use of fibrates was a significant risk factor for stopping cholesterol-lowering drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of spontaneous reports of suspected adverse reactions related to medical cannabis from the Italian Phytovigilance System.

British journal of clinical pharmacology·2026
Same author

Comparative analysis of the information reported on labels of medicinal products containing new active substances between Europe and the USA.

Annali dell'Istituto superiore di sanita·2026
Same author

Comments on: Italian Medicines Agency's reform and time until pricing and reimbursement decisions: a time-to-event analysis.

Global & regional health technology assessment·2026
Same author

Safety of influenza vaccine during the vaccination campaign 2021/2022 in Italy: a self-controlled case series study.

Vaccine·2026
Same author

Comparative risk of serious infections across biological drugs in patients with psoriatic arthritis or psoriasis: A target trial emulation using the Italian VALORE distributed database network.

Pharmacological research·2026
Same author

Global & regional health technology assessment·2026

Area of Science:

  • Pharmacoeconomics
  • Cardiovascular Pharmacology

Background:

  • Cerivastatin was withdrawn globally in August 2001 due to elevated rhabdomyolysis risk compared to other statins.
  • This withdrawal prompted an examination of its impact on cholesterol-lowering drug usage patterns.

Purpose of the Study:

  • To compare cholesterol-lowering drug use in Italy pre- and post-cerivastatin market removal.
  • To assess the influence of the cerivastatin withdrawal on patient compliance and physician prescribing behaviors.

Main Methods:

  • Retrospective analysis of cholesterol-lowering drug prescription data in Italy.
  • Comparison of statin discontinuation rates before and after August 2001.
  • Identification of risk factors associated with statin discontinuation.

Related Experiment Videos

Main Results:

  • Following cerivastatin withdrawal, 48% of its users ceased all statin treatment.
  • Concomitant use of fibrates emerged as a primary risk factor for statin discontinuation (OR = 2.3).
  • An estimated 5% increase in statin discontinuation, affecting approximately 200,000 patients, occurred in autumn 2001.

Conclusions:

  • The market withdrawal of cerivastatin significantly impacted statin adherence in Italy.
  • Physicians and patients exhibited altered prescribing and compliance patterns post-withdrawal, particularly when fibrates were co-prescribed.